Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Martin R Jones"'
Autor:
Basile Tessier‐Cloutier, Jasleen K Grewal, Martin R Jones, Erin Pleasance, Yaoqing Shen, Ellen Cai, Chris Dunham, Lynn Hoang, Basil Horst, David G Huntsman, Diana Ionescu, Anthony N Karnezis, Anna F Lee, Cheng Han Lee, Tae Hoon Lee, David DW Twa, Andrew J Mungall, Karen Mungall, Julia R Naso, Tony Ng, David F Schaeffer, Brandon S Sheffield, Brian Skinnider, Tyler Smith, Laura Williamson, Ellia Zhong, Dean A Regier, Janessa Laskin, Marco A Marra, C Blake Gilks, Steven JM Jones, Stephen Yip
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 8, Iss 4, Pp 395-407 (2022)
Abstract In this study, we evaluate the impact of whole genome and transcriptome analysis (WGTA) on predictive molecular profiling and histologic diagnosis in a cohort of advanced malignancies. WGTA was used to generate reports including molecular al
Externí odkaz:
https://doaj.org/article/a901dba17e554a43930f20607375541d
Publikováno v:
CHIMIA, Vol 74, Iss 3, Pp 122-128 (2020)
Harmful cyanobacterial blooms in freshwater ecosystems produce bioactive secondary metabolites including cyanopeptides that pose ecological and human health risks. Only adverse effects of one class of cyanopeptides, microcystins, have been studied ex
Externí odkaz:
https://doaj.org/article/dc68f4b8717f4c96937862ab3d793393
Autor:
François Busquet, Jeanne Laperrouze, Katica Jankovic, Tamara Krsmanovic, Tomasz Ignasiak, Benedetta Leoni, Gordana Apic, Giovanni Asole, Roderic Guigó, Paolo Marangio, Emilio Palumbo, Silvia Perez-Lluch, Valentin Wucher, Anna Hendrika Vlot, Robert Anholt, Trudy Mackay, Beate I. Escher, Nico Grasse, Julia Huchthausen, Riccardo Massei, Thorsten Reemtsma, Stefan Scholz, Gerrit Schüürmann, Maria Bondesson, Peter Cherbas, Jonathan H. Freedman, Stephen Glaholt, Jessica Holsopple, Stephen C. Jacobson, Thomas Kaufman, Ellen Popodi, Joseph J. Shaw, Shannon Smoot, Jason M. Tennessen, Gary Churchill, Christina Cramer von Clausbruch, Thomas Dickmeis, Gaëlle Hayot, Giuseppina Pace, Ravindra Peravali, Carsten Weiss, Nadezda Cistjakova, Xin Liu, Andis Slaitas, James (Ben) Brown, Rafael Ayerbe, Joan Cabellos, Elena Cerro-Gálvez, María Diez-Ortiz, Verónica González, Rubén Martínez, Patricia Solórzano Vives, Rosemary Barnett, Thomas Lawson, Robert G. Lee, Elena Sostare, Mark Viant, Roland Grafström, Vesa Hongisto, Pekka Kohonen, Konrad Patyra, Pradeep Kumar Bhaskar, Marcial Garmendia-Cedillos, Ibraheem Farooq, Brian Oliver, Tom Pohida, Ghadi Salem, Daniel Jacobson, Elisabeth Andrews, Marianne Barnard, Aleksandra Čavoški, Anurag Chaturvedi, John K. Colbourne, David J.T. Epps, Laura Holden, Martin R. Jones, Xiaojing Li, Ferenc Müller, Agata Ormanin-Lewandowska, Luisa Orsini, Ruth Roberts, Ralf J.M. Weber, Jiarui Zhou, Mu-En Chung, Juan Carlos Gonzalez Sanchez, Gaurav D. Diwan, Gurdeep Singh, Uwe Strähle, Robert B. Russell, Dominique Batista, Susanna-Assunta Sansone, Philippe Rocca-Serra, David Du Pasquier, Gregory Lemkine, Barbara Robin-Duchesne, Andrew Tindall
The goal of PrecisionTox is to overcome conceptual barriers to replacing traditional mammalian chemical safety testing by accelerating the discovery of evolutionarily conserved toxicity pathways that are shared by descent among humans and more distan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::876b7659dcbf87711644cfc5deccdefc
https://ora.ox.ac.uk/objects/uuid:bed21c1b-b26c-4b6d-aea0-dce1e848c810
https://ora.ox.ac.uk/objects/uuid:bed21c1b-b26c-4b6d-aea0-dce1e848c810
Autor:
Cameron J. Grisdale, Scott D. Brown, Kevin Y. Fan, Wei Zhang, Caralyn Reisle, Zoltan Bozoky, Robert A. Holt, Tariq Vira, Richard Corbett, Melika Bonakdar, My Linh Thibodeau, Kathleen Wee, Dean Cheng, Luka Culibrk, Marcus Carreira, David F. Schaeffer, Deirdre Weymann, Anna V. Tinker, Eric Y. Zhao, Michael K.C. Lee, Karen A. Gelmon, Karen Mungall, Richard A. Moore, Dean A. Regier, Daniel J. Renouf, Zusheng Zong, Reva Shenwai, Stephen Chia, Jahanshah Ashkani, Ana Fisic, Stephen Yip, Darryl D’Souza, Yussanne Ma, Daniel MacMillan, Erin Pleasance, Steve Bilobram, Alexandra Fok, Amir Muhammadzadeh, Jean-Michel Lavoie, Martin R. Jones, Hillary Pearson, Simon K. Chan, Balvir Deol, Steven J.M. Jones, Andrew J. Mungall, Mya Warren, Gregory A. Taylor, Elisa Majounie, Harwood H. Kwan, Eric Chuah, Howard John Lim, Sara Sadeghi, Dustin Bleile, Emma Titmuss, Reanne Bowlby, Anna Davies, Laura Williamson, Jessica Nelson, Caleb Choo, Jasleen K. Grewal, Katherine Dixon, Yongjun Zhao, Shehara Mendis, Yaoqing Shen, Janessa Laskin, Joanna M. Karasinska, Veronika Csizmok, Tina Wong, Sophie Sun, Kasmintan A. Schrader, Marco A. Marra
Publikováno v:
Nature Cancer. 1:452-468
Advanced and metastatic tumors with complex treatment histories drive cancer mortality. Here we describe the POG570 cohort, a comprehensive whole-genome, transcriptome and clinical dataset, amenable for exploration of the impacts of therapies on geno
Autor:
Arpad Danos, Obi L. Griffith, Jake Lever, Jasleen K. Grewal, Martin R. Jones, Luka Culibrk, Steven J.M. Jones, Melika Bonakdar, Malachi Griffith, Kilannin Krysiak
Publikováno v:
Genome Medicine, Vol 11, Iss 1, Pp 1-16 (2019)
Genome Medicine
Genome Medicine
Background Precision oncology involves analysis of individual cancer samples to understand the genes and pathways involved in the development and progression of a cancer. To improve patient care, knowledge of diagnostic, prognostic, predisposing, and
Autor:
Janessa Laskin, Sharlene Gill, Jennifer J. Knox, David F. Schaeffer, Martin R. Jones, Marco A. Marra, Howard John Lim, Daniel J. Renouf, James T. Topham, Steven Gallinger, Hui-Li Wong, Karen Mungall, Julie Ho, Richard A. Moore, Angela Goytain, Malcolm J. Moore, Steven J.M. Jones, Yussanne Ma, Andrew J. Mungall, Laura Williamson, Wei Zhang, Robert E. Denroche, Yaoquing Shen, Michael K.C. Lee, Erin Pleasance, Sara Sadeghi, Gun-Ho Jang, Stephen Yip, Joanna M. Karasinska, Carolyn Reisle, Tony Ng, John Paul McGhie
Publikováno v:
Clinical Cancer Research. 25:4674-4681
Purpose: Gene fusions involving neuregulin 1 (NRG1) have been noted in multiple cancer types and have potential therapeutic implications. Although varying results have been reported in other cancer types, the efficacy of the HER-family kinase inhibit
Autor:
Khaled A. Tolba, Martin R. Jones, Christoph Heining, Valerie Gounant, Flavio Solca, Benjamin A. Weinberg, Daniel J. Renouf, Agnieszka Cseh, Domenico Trombetta, Alexander Drilon, Lucia Anna Muscarella, Stephen V. Liu, Yasushi Goto, Janessa Laskin, Michael Duruisseaux, Parneet Cheema, Eva Brandén, Jacques Cadranel, Richard F. Schlenk
Publikováno v:
The oncologist. 26(1)
BackgroundNeuregulin 1 (NRG1) fusions, which activate ErbB signaling, are rare oncogenic drivers in multiple tumor types. Afatinib is a pan-ErbB family inhibitor that may be an effective treatment for NRG1 fusion-driven tumors.Patients and MethodsThi
Autor:
Cheryl Ho, Kathleen Wee, Laura Williamson, Daniel J. Renouf, Stephen Yip, Erin Pleasance, Martin R. Jones, Marco A. Marra, Elisa Majounie, Steven J.M. Jones, Janessa Laskin, Howard John Lim
Publikováno v:
Cold Spring Harbor Molecular Case Studies
Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers worldwide and represents a heterogeneous group of tumors, the majority of which are treated with a combination of surgery, radiation, and chemotherapy. Fluoropyrimidine (
Autor:
Martin R. Jones, Howard John Lim, Caralyn Reisle, Bruno M. Grande, Joanna M. Karasinska, Daniel J. Renouf, Marco A. Marra, Ryan D. Morin, Peter Eirew, Hui-Li Wong, Steve E. Kalloger, Stephen Yip, David F. Schaeffer, Erin Pleasance, Eric Y. Zhao, Kasmintan A. Schrader, Steven J.M. Jones, Janessa Laskin, Yaoqing Shen
Publikováno v:
JCO Precis Oncol